Ann: Imugene completes $35M Placement & Launches c.$30M SPP, page-56

Not so flattering Headline News with some sad statistics.

BUZZ-Australia's Imugene hits near 3-year low on discounted share placement

18 08 2023 10:45am AEST

** Shares of Australia's Imugene fall 14.9% to A$0.080, hits lowest since Nov. 13, 2020
** Stock set to mark worst day since Oct.28, 2022
** Clinical-stage immune-oncology company completes A$35 million ($22.45 million) share placement at an issue price of A$0.084 per share
** Offer price is at a discount of 10.6% to the last close of co
** Stock has fallen 35.2% this year as of last close ($1 = 1.5593 Australian dollars)